CER budgets heading up in '12
November 01 2011
More than half of drug companies plan to increase spending for market-access activities in 2012, including comparative effectiveness research (CER), ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.